Isolation of Shiga toxin-producing Escherichia coli from raw milk in Kermanshah, Iran
,
Abstract
Background and Objectives: Infectious diarrhoeal diseases are great problem throughout the world and are responsible for considerable morbidity and mortality. Shiga toxin-producing Escherichia coli (STEC) is a major cause of gastroenteritis that may be complicated by hemorrhagic colitis (HC) or the hemolytic uremic syndrome (HUS), which is the main cause of acute renal failure in children. Food-borne outbreaks associated with Shiga toxin-producing Escherichia coli have been well documented worldwide.The aim of this study was to investigate the prevalence of Shiga toxin-producing Escherichia coli (STEC) strains in raw milk samples.
Materials and Methods: Raw milk samples collected from various cow farms in Kermanshah, Iran during June – September 2009 were investigated for STEC using PCR targeting stx1 and stx2 and then eaeA.206 samples, 36 (17.47%) were contaminated with STEC. STEC isolates harbored 56.41% and 43.59% stx and stx gene respectively. In antibiotic resistance test, all strains were sensitive to ceftazidime, cefepime, gentamicin, imipenem and ciprofloxacin. 23.08% of isolates were resistat to tetracycline, and 38.5% of them showed intermediate sensitvity to cephalothin.
Conclusions: The high presence of STEC in raw milk confirms the important role of raw milk as putative vehicle of infection to human. Moreover, this study suggests that the development of antibiotic resistant STEC must be a major concern in Iran and more studies are needed to identify the prevalence of STEC in other food samples.
Louie M, De Azavedo JC, Handelsman MY, Clark CG, Ally B, Dytok M. Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. Infect Immun 1993; 61: 4058-4092.
Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin Microbiol Rev 1998; 11: 450-479.
Karmali MA. Infection by Verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2: 5-38.
4. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli.Clin Microbiol Rev 1998; 11: 142-201.
Beutin L, Kaulfuss S, Cheasty T, Brandenburg B, Zimmermann S, Gleier K, et al. Characteristics and association with disease of two major subclones of Shiga toxin (Verocytotoxin)-producing strains of Escherichia coli (STEC) O157 that are present among isolates from patients in Germany. Diagn Microbiol Infect Dis 2002;44: 337-346.
Willshaw GA, Cheasty T, Smith HR, O’Brien SJ.Adak GK. Vero cytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales. 1995-1998. J Med Microbiol 2001; 50: 135-142.
Bettelheim KA. Role of non-O157 VTEC. J Appl Microbiol, 2000; 88: 38S-50S.
Louie M, Read S, Louie L, Ziebell K, Rahn K, Borczyk A, et al. Molecular typing methods to investigate transmission of Escherichia coli O157:H7 from cattle to humans. Epidemiol Infect 1999; 123: 17-24.
Reilly A. Prevention and control of enterohaemorrhagic Escherichia coli (EHEC) infections: memorandum from a WHO meeting. WHO Consultation on Prevention and Control of Enterohaemorrhagic Escherichia coli (EHEC) Infections. Bulletin of World Health Organization 1998;76: 245-255.
Walterspiel J, Ashkenazi S, Morrow A, Cleary TG.Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin 1. Infection 1992; 20: 25-29.
Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI.The risk of hemolytic–uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections, New Engl. J. Med 2000; 342: 1930-1936.
Zhangb X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK Acheson DW Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000; 181: 664-670.
Fukushima H, Hashizume T, Morita Y, Tanaka J, Azuma K, Mizumoto Y, et al. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City. Pediatrics International 1999; 41: 213-217.
Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Effect of early fosfomycin treatment on prevention of hemolytic–uremic syndrome accompany- ing Escherichia coli O157:H7 infection. Clin Nephrol 1999; 52: 357-362.
Farina C, Goglio A, Conedera G, Minelli F, Caprioli A. Antimicrobial susceptibility of Escherichia coli O157 and other enterohemorrhagic other Shiga toxin- producing Escherichia coli strains Escherichia coli isolated in Italy. Eur J Clin Microbiol Infect Dis 1996;15: 351-353.
Schroeder CM, Zhao C, DebRoy C, Torcolini J, Zhao S, White DG, et al. Antimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and food. Appl Environ Microbiol 2002; 68: 576-581.
Mora A, Blanco JE, Blanco M, Alonso MP, Dhabi G., Echeita A, et al. Antimicrobial resistance of Shiga toxin (Verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Res Microbiol 2005; 156: 793-806.
Farmer JJ, Boatwright KD, Janda JM. (2007).
Enterobacteriaceae: Introduction and Identification. In: Murray PR, Barron EJ, Jorgensen JH, Landry ML, Pfaller MA :Ed : Manual of clinical microbiology. ASM, Washington DC, vol. 1, pp. 649-669.
Pollard DR, Johnson MW, Lior H, Tyler SD, Rozee KR. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 1990; 28: 540-545.
Svenugsson B, Lagergren A, Ekwall E, Evengard B, Hedlund KO, Karnell A. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 2000; 30: 770-778.
Desmarchelier PM, Bilge SS, Fegan N, Mills L, Vary Jr JC, Tarr PI. A PCR specific for Escherichia coli O157 based on the rfb locus encoding O157 lipopolysaccharide. J Clin Microbiol 1998; 36: 1801-1804.
Gannon VP, D’Souza S, Graham T, King RK, Rahn K, Read S. Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains. J Clin Microbiol 1997; 35: 656-662.
Bauer AW, Kirby W, Sherris JC, Truck, M. Antibiotic susceptibility testing by a standardized single disc method. American J Clin Pathol 1966; 45: 493-496.
Adwan GM, Adwan KM. Isolation of Shiga toxigenic Escherichia coli from raw beef in Palestine. Int J Food Microbiol 2004; 97: 81-84.25. Paton AW, Ratcliff RM, Doyle RM, Seymour-Murray J, Davos D, Lanser JA, et al. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like-producing Escherichia coli. J Clin Microbiol 1996, 34: 1622-1627.
Stanford K, Croy D, Bach SJ, Wallins GL, Zahiroddini H, McAllister TA. Ecology of Escherichia coli O157:H7 in commercial dairies in Southern Alberta. J Dairy Sci 2005; 88: 4441-4451.
Parisi A, Miccolupo A, Santagada G, Pedarra C, Dambrosio A, Normanno G. Detection of Verocytotoxin- producing Escherichia coli (VTEC) in minced beef and raw milk by colony blot hybridization. Food Control 2010; 21: 770-773.
Klie H, Timm M, Richter H, Gallien P, Perlberg KW, Steinruck H. Detection and occurrence of Vertoxinfor- ming and/or Shigatoxin producing Escherichia coli (VTEC and/or STEC in milk). Berliner and Munchener Tierarztliche Wochenschrift 1997; 337-341.
Steele ML, McNab WB, Poppe C, Griffiths MW, Chen S, Degrandis SA. Survey of Ontario bulk tank milk for foodborne pathogens. J Food Prot 1997; 60: 1341-1346.
Perelle S, Dilasser F, Grout J, Fach P. Screening food raw materials for the presence of the world’s most frequent clinical cases of Shiga toxin-encoding Escherichia coli O26, O103, O111, O145 and O157. Int J Food Microbiol 2007; 113: 284-288.
Arthur TM, Barkocy-Gallagher GA, Rivera-Betancourt M, Koohmaraie M Prevalence and characterization of non-O157 Shiga toxin-producing Escherichia coli on carcasses in commercial beef cattle processing plants. Appl Environ Microbiol 2002; 68: 4847-4852.
Slanec T, Fruth A, Creuzburg K, Schmidt H. Molecular analysis of virulence profiles and Shiga Toxin genes in food-borne Shiga toxin-producing Escherichia coli. Appl Environ Microbiol 2009; 75: 6187-6197.
Beutin L (1999). Escherichia coli O157 and other types of Verocytotoxigenic E.coli (VTEC) isolated from humans, animals and food in Germany. In: Escherichia coli O157 in Farm Animals. Ed. CS Stewart, HJ Flint. CABI Publishing, UK, pp. 121-145.
Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. Associations between virulence factors of shiga toxinproducing Escherichia coli and disease in humans. J Clin Microbiol 1999; 37: 497-503.
Paton AW, Woodrow MC, Doyle RM, Lanser JA, Paton JC. Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J Clin Microbiol 1999; 37: 3357-3361.
Coia JE, Johnston Y, Steers NJ, Hanson MF. A survey of the prevalence of Escherichia coli O157 in raw meats, raw cow’s milk and raw-milk cheeses in south- east Scotland. Int J Food Microbiol 2001; 66: 63-69.
Meng J, Zhao S, Zhao T, Doyle MP. Molecular characterization of Escherichia coli O157:H7 isolates by pulsed-field gel electrophoresis and plasmid DNA analysis. J Med Microbio 1999; 42: 258-263.
Padhye NV, Doyle MP. Rapid procedure for detecting enterohemorrhagic Escherichia coli O157:H7 in food. Appl Environ Microbiol 1991; 57: 2693-2698.
Salmanzadeh-Ahrabi S, Habibi E, Jaafari F, Zali MR.Molecular epidemiology of Escherichia coli diarrhea in children in Tehran. Ann Trop Paediatr 2005; 25: 35-39.
Aslani MM, Bouzari S. An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces). Eur J Epidemiol 2003; 18: 345-349.
AlikhaniMY,MirsalehianA,FatollahzadehB,Pourshafie MR, Aslani MM. Prevalence of enteropathogenic and Shiga toxin-producing Escherichia coli among children whit and without diarrhea in Iran. J Health Popul Nutr 2007; 25, 88-93.
Jafari F, Garcia-Gil LJ, Salmanzadeh-Ahrabi S, Shokrzadeh L, Aslani MM, Pourhoseingholi MA, et al. Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children’s hospitals. J Infect 2009; 58: 21-27.
Witte W. Medical consequences of antibiotic use in agriculture. Science 1998; 279: 996-997.
Singh R, Schroeder CM, Meng J, White DG, McDermott PF, Wagner DD. Identification of antimicrobial resistance and class 1 integrons in Shiga toxin- producing Escherichia coli recovered from humans and food animals. J Antimicrobial Chemotherapy 2005; 56:216-219.
Khan A, Das SC, Ramamurthy T, Sikdar A, Khanam J, Yamasaki S. et al. Antibiotic resistance, virulence gene, and molecular profiles of Shiga toxin-producing Escherichia coli isolates from diverse sources in calcutta, India. J Clin Microbiol 2002; 40: 2009-2015.
Baghbani-Arani F, Salmanzadeh-Ahrabi S, Jafari F, Habibi E. Zali MR. Isolation of Shiga toxin-producing Escherichia coli (STEC) from meat samples by PCR in Tehran and evaluation of antibacterial patterns of isolated strains. Pejouhandeh Bimonthly Res. J. 2007;56: 107-114.
| Files | ||
| Issue | Vol 5 No 3 (2013) | |
| Section | Articles | |
| Keywords | ||
| Antimicrobial resistance Iran STEC raw milk | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
